Dexamethasone treatment for congenital adrenal hyperplasia.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2334212.
- Also identified by PMC identifier 1792315.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ten patients with congenital adrenal hyperplasia (three males, seven females; aged 12-29 years) had their usual glucocorticoid treatment changed to dexamethasone in three crossover dosage regimens. A starting dose of 5 micrograms/kg/day is suggested but as no one dose regimen resulted in adequate control the timing of the dose must be decided for each patient.
Medical subject headings
- Adrenal Hyperplasia, Congenital
- Dexamethasone